Company Profile

SeQuent is looking towards the future with courage and confidence, because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation) and Human health (API).

We have branded our Animal Health business as Alivira Animal Health with a singular focus to create value in the global animal health space. We cater to unaddressed global market requirements and focus on products for livestock, poultry and companion animals. Our value proposition includes laboratory and technical support services.

For our Human Health business we are focused on the development and supply of high-value, low-volume APIs. We are operating across multiple therapeutic segments, such as anti-malarial, anthelmintics, anti-infective, antiviral, central nervous system (CNS) and dermatology.

We are equipped to cater to the domestic and global demands with cutting-edge R&D, highly flexible manufacturing capabilities and a competitive supply-chain network.

Sequent | Proven Ability In Life Secience